PLSE · Pulse Biosciences Inc
United States · RS rating 97 · As of 2026-11-03
| Price | 52.20 USD |
|---|---|
| 1-day change | -1.3% |
| RS rating (overall / 1M / 3M / 12M) | 97 / 67 / 94 / 97 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 53 / 79 / 51 |
| Industry group (rank) | Medical-Systems/Equip (86) |
| EPS growth Q/Q | +10.3% |
| Sales growth Q/Q | +207.0% |
| Distance from 52-week high | +5.9% |
| Market cap (USD) | $1.6B |